http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002500671-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-94 |
| filingDate | 1998-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2002-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2002500671-A |
| titleOfInvention | Use of nitroxide or a prodrug thereof in the prevention and treatment of cancer |
| abstract | (57) Summary The present invention provides a method for preventing and treating cancer. The method comprises administering a nitroxide or a prodrug thereof to an animal, preferably a mammal, more preferably a human at risk of developing or having cancer, wherein the nitroxide or a prodrug thereof is preferably A cycloaliphatic or heterocyclic compound, more preferably a compound of formula (I) or (II), administered in an amount sufficient to prevent or treat said cancer, wherein said cancer comprises said nitroxide Or susceptible to prophylaxis or treatment with a prodrug thereof. Also provided is a composition for use in the method. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007500227-A |
| priorityDate | 1997-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 82.